• Molecular & Cellular Toxicology
• /
• 제3권3호
• /
• pp.198-207
• /
• 2007

[ $^{18}F$ ]-fluorodeoxyglucose (FDG) uptake on positron emission tomography (PET) scan has been found to reflect tumor aggressiveness and prognosis in various types of cancer. In this study, the gene expression profiles of glial tumors were evaluated to determine whether glial tumors with high $^{18}F$-FDG uptake have more aggressive biological potential than with low uptake. Surgical specimens were obtained from the 12 patients with glial tumors (4 males and 8 females, age range 42-68 years). The tumor samples were divided into two groups based on the $^{18}F$-FDG uptake PET scan findings: high $^{18}F$-FDG uptake (n=4) and low $^{18}F$-FDG uptake (n=8). The pathological tumor grade was closely correlated with the $^{18}F$-FDG uptake pattern: Glial tumors with high $^{18}F$-FDG uptake were pathologically Edmondson-Steiner grade III, while those with low uptake were grade II. The total RNA was extracted from the frozen tissues of all glial tumors (n=12), and adjacent non-cancerous tissue (n=3). The gene expression profiles were evaluated using cDNA microarray. The glial tumors with high $^{18}F$-FDG uptake showed increase expression of 15 genes compared to those with low uptake (P<0.005). Nine genes were down-regulated. Gene expression is closely related to cell survival, cell-to-cell adhesion or cell spreading; therefore, glial tumors with high $^{18}F$-FDG uptake appear to have more aggressive biological properties than those with low uptake.

• Radiation Oncology Journal
• /
• 제31권3호
• /
• pp.111-117
• /
• 2013

Purpose: To determine whether the maximum standardized uptake value (SUV) of [$^{18}F$] fluorodeoxyglucose uptake by positron emission tomography (FDG PET) ratio of lymph node to primary tumor (mSUVR) could be a prognostic factor for node positive non-small cell lung cancer (NSCLC) patients treated with definitive radiotherapy (RT). Materials and Methods: A total of 68 NSCLC T1-4, N1-3, M0 patients underwent FDG PET before RT. Optimal cutoff values of mSUVR were chosen based on overall survival (OS). Independent prognosticators were identified by Cox regression analysis. Results: The most significant cutoff value for mSUVR was 0.9 with respect to OS. Two-year OS was 17% for patients with mSUVR > 0.9 and 49% for those with mSUVR ${\leq}0.9$ (p = 0.01). In a multivariate analysis, including age, performance status, stage, use of chemotherapy, and mSUVR, only performance status (p = 0.05) and mSUVR > 0.9 (p = 0.05) were significant predictors of OS. Two-year OS for patients with both good performance (Eastern Cooperative Oncology Group [ECOG] ${\leq}1$) and mSUVR ${\leq}0.9$ was significantly better than that for patients with either poor performance (ECOG > 1) or mSUVR > 0.9, 23% (71% vs. 23%, p = 0.04). Conclusion: Our results suggested that the mSUVR was a strong prognostic factor among patients with lymph node positive NSCLC following RT. Addition of mSUVR to performance status identifies a subgroup at highest risk for death after RT.

• Nuclear Medicine and Molecular Imaging
• /
• 제40권5호
• /
• pp.271-274
• /
• 2006

We report the case of a 64-year-old man with superior vena cava (SVC) syndrome due to tumor thrombus from recurrent hepatocellular carcinoma (HCC). He presented with new onset of facial swelling for 10 days. HCC was detected ten years ago. He has undergone repeated transcatheter arterial embolization (TAE) and chemotherapy. Chest computed tomography (CT) demonstrated tumor thrombus in the SVC extending to right atrium. He underwent whole body F-18 fluorodeoxyglucose(FDG) positron emission tomography/computed tomography (PET/CT) scanning for assessing the effect of TAE in HCC. F-18 FDG PET/CT showed increased uptake in the residual liver mass indicating viable tumor. There was another intense F-18 FDG accumulation in SUV extending to right atrium to suggest tumor thrombus. This case illustrates that F-18 FDG PET/CT is useful to identification of distant metastases as well as assessment of response to therapy in long-term survival HCC patients.

• 대한방사선기술학회지:방사선기술과학
• /
• 제39권3호
• /
• pp.369-376
• /
• 2016

양전자방출단영상(Positron Emission Tomography, PET)은 여러 화합물과 방사성 동위원소를 결합하여 인체 내에 주입하여 인체 내의 대사율을 정량적으로 측정할 수 있는 핵의학적 검사이다. 특히, 암 조직에서 포도당 대사가 증가되는 현상을 $^{18}F$-FDG(Fluorodeoxyglucose)를 사용하여 널리 암 진단에 활용하며, 현대에서 발병 빈도가 높은 뇌질환 중 치매 및 파킨슨 진단에도 높은 유용성을 보인다는 연구가 다수 진행되었다. 이러한 현재의 정적 정보에 시간의 동적 정보를 포함하는 동적 양전자방출단층영상(dynamic PET, dPET)을 이용할 경우, 진단을 위한 추가적인 정보가 제공되므로 진단의 정확도 향상에 기여할 수 있다. 이러한 이유로 임상 연구자 및 방사선사의 큰 관심을 받고 있으나 연구를 진행하기 위해 손쉽게 사용 가능한 도구가 부족한 실정이며, 다양하고 복잡한 수학적 알고리즘(algorithm)이나 프로그래밍(programming) 기술이 부족할 경우 연구의 활성화를 방해하는 높은 진입장벽으로 존재하게 되므로, 본 연구에서는 dPET 연구의 활성화와 손쉬운 사용을 위해서 MATLAB을 이용하여 그래픽 유저(GUI) 기반으로 하여 무료 소프트웨어를 개발하였으며, 개발된 소프트웨어인 DIA-Tool(Dynamic Image analysis-Tool)은 복잡한 수학적 영상 분석 알고리즘을 누구나 손쉽게 사용할 수 있도록 설계되었다. 향후, 많은 임상 연구자들이 DIA-Tool을 이용하여 국내의 dPET 연구 발전에 큰 도움이 될 것이라 기대된다.

• Nuclear Medicine and Molecular Imaging
• /
• 제40권4호
• /
• pp.233-236
• /
• 2006

A 67-year-old man with a history of chronic obstructive pulmonary disease (COPD) underwent F-18 fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) for staging of gastric cancer. The projection images of F-18 FDG PET/CT showed intensely increased F-18 FDG uptake in the anterior neck, chest wall, and upper abdomen. We suspected distant metastases of cervical lymph nodes, ribs, and peritoneum in gastric canter. However, the transaxial images of F-18 FDG PET/CT showed abnormal F-18 FDG uptake in scalene muscles of anterior neck, intercostal muscles of chest wall, and diaphragm of upper abdomen. Patients with COPD use respiratory muscles extensively on the resting condition. These excessive physiologic use of respiratory muscles causes increased F-18 FDG uptake as a result of increased glucose metabolism. The F-18 FDG uptake in respiratory muscles of gastric cancer patient with COPD mimicked distant metastases in cervical lymph nodes, ribs, and peritoneum.

• Nuclear Medicine and Molecular Imaging
• /
• 제40권5호
• /
• pp.275-278
• /
• 2006

We report the case of a 73-year-old man who had prostate cancer with bone metastases. Tc-99m HDP Whole body bone scan revealed multiple areas of increased bony uptake consistent with widespread bone metastases. F-18 fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) demonstrated mild F-18 FDG uptake in the lymph nodes of neck, abdomen, and pelvis. However, abnormal F-18 FDG uptake was not seen in the skeletal system. Biopsy and immunohistochemical stains of left supraclavicular mass showed metastatic prostate adenocarcinoma. Currently, there are a few reported cases of F-18 FDG PET/CT evaluation of bone metastases in prostate cancer. We discuss the discrepancy between F-18 FDG PET/CT and bone scan in the detection of osseous metastases of prostate cancer.

• Journal of Chest Surgery
• /
• 제45권1호
• /
• pp.35-39
• /
• 2012

Background: The aims of the study were to determine the accuracy of fluorodeoxyglucose positron emission tomography (FDG-PET) in detecting pulmonary metastasis through video-assisted thoracoscopic surgery (VATS), a technique that allows the excisional biopsy of small pulmonary nodules in patients with known malignancies. Materials and Methods: Between October 2007 and April 2010, 28 patients with known malignancies and small pulmonary nodules underwent VATS excisional biopsies. All patients were in follow-up for a previously treated malignancy. The malignancies included the following: colorectum (9), breast (6), head and neck (5), stomach (3), lymph (1), ovary (1), uterus (1), bladder (1), and liver (1). Results: There were 16 men and 12 women whose mean age was 56.7 years old (range, 38 to 77 years). The sizes of the mean nodules removed were 11.3 mm (range, 7 to 21 mm). Diagnoses included metastatic (11), bronchioloalveolar carcinoma (1), primary adenocarcinoma (1), pulmonary tuberculosis (6), fibrosis (5), organizing pneumonia (3), lymphoid hyperplasia (1). Among these lesions, 46.4% were malignant. Conclusion: True positive FDG-PET was 39.2%. FDG-PET is not a sensitive test in the evaluation of patients with a history of an extrathoracic malignancy and newly diagnosed small pulmonary nodules. VATS excision allows the early diagnosis of small pulmonary nodules, with low morbidity, in patients with known malignancies.

• Nuclear Medicine and Molecular Imaging
• /
• 제43권6호
• /
• pp.582-587
• /
• 2009

A 59-year-old woman who was diagnosed with malignant pheochromocytoma underwent $^{18}F$-fluorodeoxyglucose positron emission tomography/computed tomography ($^{18}F$-FDG PET/CT). She had undergone left adrenalectomy for pheochromocytoma 4 years previously. Recent multiple metastatic pulmonary nodules were noted on the chest X-ray. After treatment with $^{131}I$-metaiodobenzylguanidine ($^{131}I$-MIBG) with 7.4 GBq, post-therapy $^{131}I$-MIBG scintigraphy depicted multiple distant metastases including lung, liver, abdominal para-aortic and mesenteric lymph nodes. $^{18}F$-FDG PET/CT also depicted multiple metastases in lung, liver, and abdominal para-aortic lymph nodes, but some lesions were not shown. In this case, $^{131}I$-MIBG scintigraphy found additional lesions in metastatic malignant pheochromocytoma.

• Nuclear Medicine and Molecular Imaging
• /
• 제41권2호
• /
• pp.97-101
• /
• 2007

Correct localization of epileptogenic zone is important for the successful epilepsy surgery. Both ictal perfusion single photon emission computed tomography (SPECT) and interictal F-18 fluorodeoxyglucose positron emission tomography (FDG-PET) can provide useful information in the presurgical localization of intractable partial epilepsy. These imaging modalities have excellent diagnostic sensitivity in medial temporal lobe epilepsy and provide good presurgical information in neocortical epilepsy. Also provide functional information about cellular functions to better understand the neurobiology of epilepsy and to better define the ictal onset zone, symptomatogenic zone, propagation pathways, functional deficit zone and surround inhibition zones. Multimodality imaging and developments in analysis methods of ictal perfusion SPECT and new PET ligand other than FDG help to better define the localization.

• 한국방사선학회논문지
• /
• 제7권5호
• /
• pp.365-369
• /
• 2013

PET(positron emission tomography)을 촬영하기 위해서는 방사선 의약품 동위원소를 사용하여 인체 내에 정맥주사를 한다. 이 경우 대표적으로 사용하는 방사선 의약품은 $^{18}FDG$ (Fluorodeoxyglucose)이다. 의료용 싸이크로트론으로 생산하는 $^{18}F$에 deoxyglucose를 합성하기 위해서 합성용 카세트장치가 필요하다. 방사성 의약품 제조시에는 많은 양의 2차 방사선이 발생이 된다. 따라서 2차 방사선을 차폐하기 위하여 핫셀(Hot cell)을 사용한다. 우리는 $^{18}FDG$ 합성 또는 분배시에 핫 셀 외부로 유출되는 선량을 측정하였다. 이번 실험은 $^{18}FDG$ 제조 작업시에 의도하지 않게 발생할 수 있는 방사선 작업종사자의 피폭에 관한 선량정보를 제공하기 위함이다. 결론적으로 핫셀 내부에서 외부로 $^{18}FDG$ 합성시에 선량이 유출됨을 확인 할 수 있었다. 특히 핫셀에서 핫셀 내부를 볼 수 있는 납유리에서 외부로 방사선이 유출되는 것을 알 수 있었다. 결론적으로 $^{18}FDG$ 합성시 방사선 작업종사자의 피폭선량을 감소하기 위해서는 핫셀 존재하는 납유리의 개선점이 필요할 것으로 사료된다.